经皮扩张气管切开术中常规纤维支气管镜监测的作用:随机对照试验方案
本研究为多中心随机对照试验方案,纳入ICU需经皮扩张气管切开(PDT)的成人患者,随机分为盲穿PDT组与内镜引导PDT组,由经验丰富的重症医师操作,主要结局为围术期并发症发生率,旨在评估常规纤维支气管镜(FB)监测在PDT中的安全性作用。
要点
- 比较盲穿与内镜引导下PDT的围术期并发症发生率。
- 由精通PDT和FB的重症医师操作,数据安全监查委员会全程監测。
- 国际指南因证据不足未对PDT中FB使用做出推荐,本研究旨在填补证据缺口。
核心结论
- 该试验旨在评估经皮扩张气管切开术中常规纤维支气管镜监测对围术期并发症的影响。
研究设计与样本
- 多中心(发文时为三个中心)随机对照临床试验,纳入连续成人ICU患者,随机分为盲穿PDT组与内镜引导PDT组。
- 纳入标准为因长期机械通气需行PDT且无FB使用排除标准的成人ICU患者。
- 所有操作由精通PDT和FB的经验丰富重症医师完成,数据安全监查委员会负责監测。
关键数值与推荐
- 主要结局为围术期并发症发生率。
- 试验注册号ClinicalTrials.gov NCT04265625,注册日期2020年2月11日。
临床怎么用
- 目前国际指南因证据不足未对PDT中常规使用FB做出推荐,临床实践尚不统一。
- 该试验结果可为PDT中是否常规使用FB监测提供随机对照证据。
局限性
- 发文时为三个中心,多中心代表性有限。
- 原文未报告样本量、效应值及统计把握度等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tracheostomy is one of the most frequent techniques in intensive care units (ICU). Fiberoptic bronchoscopy (FB) is a safety measure when performing a percutaneous dilatational tracheostomy (PDT), but the controversy surrounding the routine use of FB as part of the procedure remains open. National surveys in some European countries showed that the use of FB is non-standardized. Retrospective studies have not shown a significant difference in complications between procedures performed with or without a bronchoscope. International guidelines have not been able to establish recommendations regarding the use of FB in PDT due to lack of evidence. DESIGN: This is a multicenter (three centers at the time of publishing this paper) randomized controlled clinical trial to examine the safety of percutaneous tracheostomy using FB. We will include all consecutive adult patients admitted to the ICU in whom percutaneous tracheostomy for prolonged mechanical ventilation is indicated and with no exclusion criteria for using FB. Eligible patients will be randomly assigned to receive blind PDT or PDT under endoscopic guidance. All procedures will be performed by experienced intensivists in PDT and FB. A Data Safety and Monitoring Board (DSMB) will monitor the trial. The primary outcome is the incidence of perioperative complications. DISCUSSION: FB is a safe technique when performing PDT although its use is not universally accepted in all ICUs as a routine practice. Should PDT be monitored routinely with endoscopic guidance? This study will assess the role of FB monitoring during PDT. TRIAL REGISTRATION: ClinicalTrials.gov NCT04265625. Registered on February 11, 2020.
引用
- Añón JM, Arellano MS, Pérez-Márquez M, et al. The role of routine FIBERoptic bronchoscopy monitoring during percutaneous dilatational TRACHeostomy (FIBERTRACH): a study protocol for a randomized, controlled clinical trial. Trials. 2021. PMID: 34187554. doi:10.1186/s13063-021-05370-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。